Arthritis
BEMER for Arthritis
Reducing inflammation and improving mobility in arthritic joints.
About this condition
Arthritis — whether osteoarthritis or rheumatoid — causes joint inflammation, pain, stiffness, and progressive loss of mobility. Poor local circulation in joint tissues compounds inflammation and slows repair.
How BEMER helps
By improving microcirculation in and around affected joints, BEMER supports better nutrient delivery to cartilage and synovial tissue, aids the removal of inflammatory waste products, and may help reduce pain and stiffness — particularly in the morning and after periods of inactivity.
Key benefits
Please note: The AFB multi-centre study (1999–2002) — 1,116 patients across 220 medical facilities, predominantly treatment-resistant cases — documented 236 cases of arthrosis/arthritis with an 83% positive outcome at 6 weeks, and 48 cases of rheumatic symptoms with 94% positive outcome. The Schönfeld general practice study (Berlin, 1999–2000) recorded 87.6% overall positive outcomes across 201 patients, with musculoskeletal acute conditions achieving 90%+ positive response. Joint pain and arthralgia (n=47) showed 92% positive response at 4 weeks in the AFB dataset. These outcomes were achieved in settings where patients' existing medications continued unchanged — BEMER was used as a complementary addition, not a replacement.